• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Retraction Note to: Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19.撤回说明：亚甲蓝光化学处理作为一种用于血液安全的可靠的严重急性呼吸综合征冠状病毒2血浆病毒灭活方法及用于2019冠状病毒病康复期血浆治疗。
BMC Infect Dis. 2021 Jul 9;21(1):672. doi: 10.1186/s12879-021-06344-9.
2
[The effect of methylene blue/photochemical method for virus inactivation on plasma components].[亚甲蓝/光化学法病毒灭活对血浆成分的影响]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003 Jun;11(3):305-7.
3
Convalescent Plasma for the Treatment of Severe COVID-19.康复期血浆治疗重症新型冠状病毒肺炎
Biologics. 2021 Feb 4;15:31-38. doi: 10.2147/BTT.S272063. eCollection 2021.
4
Effects and Safety of Convalescent Plasma Administration in a Group of Polish Pediatric Patients with COVID-19: A Case Series.一组波兰新冠病毒肺炎儿科患者接受恢复期血浆治疗的疗效与安全性：病例系列报告
Life (Basel). 2021 Mar 17;11(3):247. doi: 10.3390/life11030247.
5
Effect of Methylene Blue Pathogen Inactivation on the Integrity of Immunoglobulin M and G.亚甲蓝病原体灭活对免疫球蛋白M和G完整性的影响。
Transfus Med Hemother. 2021 May;48(3):148-153. doi: 10.1159/000514485. Epub 2021 Feb 25.
6
A 63-Year-Old Woman with SARS-CoV-2 Infection, Who Developed Severe COVID-19 Pneumonia and Was Supported with Convalescent Plasma Therapy.一名63岁感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的女性，她发展为重症冠状病毒病2019（COVID-19）肺炎并接受了恢复期血浆治疗。
Am J Case Rep. 2020 Sep 29;21:e927662. doi: 10.12659/AJCR.927662.
7
Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human plasma.氨甲蝶呤和长波紫外线 A 光疗能有效使人类血浆中的严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）失活。
Vox Sang. 2021 Jul;116(6):673-681. doi: 10.1111/vox.13043. Epub 2020 Dec 5.
8
The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2.新冠病毒高滴度康复期血浆的证据
SN Compr Clin Med. 2021;3(3):790-792. doi: 10.1007/s42399-021-00827-1. Epub 2021 Feb 18.
9
In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2.亚甲蓝单独或联合使用对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗病毒活性的体外评估
J Clin Med. 2021 Jul 6;10(14):3007. doi: 10.3390/jcm10143007.
10
Potential benefits, mechanisms, and uncertainties of convalescent plasma therapy for COVID-19.新冠康复者血浆疗法的潜在益处、作用机制及不确定性
Blood Sci. 2020 Jun 24;2(3):71-75. doi: 10.1097/BS9.0000000000000047. eCollection 2020 Jul.

引用本文的文献

1
Chitosan-Based Formulations Intended as Protective Spray for Mask Surfaces in Prevention of Coronavirus Dissemination.旨在作为口罩表面防护喷雾剂以预防冠状病毒传播的壳聚糖基制剂。
ChemistrySelect. 2022 Oct 7;7(37):e202202410. doi: 10.1002/slct.202202410. Epub 2022 Oct 4.
2
Anti-Viral Photodynamic Inactivation of T4-like Bacteriophage as a Mammalian Virus Model in Blood.抗病毒光动力失活 T4 样噬菌体作为血液中的哺乳动物病毒模型。
Int J Mol Sci. 2022 Sep 30;23(19):11548. doi: 10.3390/ijms231911548.

Retraction Note to: Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19.

作者信息

Jin Changzhong, Yu Bin, Zhang Jie, Wu Hao, Zhou Xipeng, Yao Hangping, Liu Fumin, Lu Xiangyun, Cheng Linfang, Jiang Miao, Wu Nanping

机构信息

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Disease, National Medical Center for Infectious Disease, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China.

Boxin (Beijing) Biotechnology Development LTD, 4/F, Tower B, Siemens Building, No. 7 South Central Road, Wangjing, Chaoyang District, Beijing, China.

出版信息

BMC Infect Dis. 2021 Jul 9;21(1):672. doi: 10.1186/s12879-021-06344-9.

DOI:10.1186/s12879-021-06344-9
PMID:34243711
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8268612/
Abstract
摘要